Reported 1 day ago
BofA Securities has reaffirmed a Buy rating for Definitive Healthcare Corp. (NASDAQ:DH), setting a price target of $4.50, indicating a potential increase of 16.3%. The company raised its revenue guidance for the year to $237-$240 million, attributed to improved client retention, and added 12 new enterprise clients in the last quarter. Analysts are optimistic about its growth prospects, focusing on retention rates and operational improvements.
Source: YAHOO